Since cytotoxic CD4+ T cells accumulate with age and the CD4 cytolytic activity was found to be comparable between all age groups upon influenza vaccination [113], a science-based strategy for designing new vaccines for the elderly could be to focus on the NP or M1 peptides that carry cytotoxic CD4+-specific epitopes. Here, CD4 is linked to influenza.